ClinVar Miner

Submissions for variant NM_000350.3(ABCA4):c.160+5G>C (rs1064793004)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000479570 SCV000564514 likely pathogenic not provided 2013-05-01 criteria provided, single submitter clinical testing The c.160+5 G>C variant in the ABCA4 gene has not been reported as a pathogenic variant or as a benign polymorphism to our knowledge. Two different in silico models predict that the c.160+5 G>C change abolishes the splice donor site of intron 2. If this is the case, it would be expected to lead to either an abnormal message which is subject to nonsense-mediated mRNA decay or to an abnormal protein product if the message is used for protein translation. The c.160+5 G>C variant was not observed in approximately 5,000 individuals of European and African American ancestry in an external variant database, indicating it is not a common benign variant in these populations. Therefore, c.160+5 G>C is a strong candidate for a pathogenic variant, however the possibility that it is a benign variant cannot be excluded.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.